DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...
For severe thrombocytopenia related to chronic liver disease, treatment options include platelet transfusion, splenic artery embolization, splenectomy, and transjugular intrahepatic portosystemic ...
Sarah Blackburn's experience highlights the importance of routine medical checkups. Despite a healthy lifestyle, a full-body ...
Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...
The patient tolerated the procedure well without complication. Follow-up CTA demonstrated successful embolization of the splenic artery aneurysm. Rapidly increasing size, presence in a premenopausal ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback